As a medical, dentistry, and psychotherapy professional, I have dedicated my life to supporting and healing others. Investing in visionary Biomed-tech was a natural extension and realises my drive to help ameliorate the world’s greatest problems. But physicians can only do so much individually; armed with the latest advancements in biomedical innovation, their ability to save lives increases exponentially.
Cytovale’s IntelliSep test is precisely the kind of miraculous invention I am honored to help bring to market. Sepsis is the number one cause of death in hospitals, requiring urgent, rapid diagnosis and intervention, as every passing moment without accurate diagnosis greatly increases the risk of death. By creating a tool that allows for rapid, affordable sepsis evaluation, Cytovale stands to save thousands of lives. As a scientific advisor and lead investor in the company, it’s been my greatest privilege to support this ground-breaking work, getting it to those it could save.